11 12.º FORO DE Inmunología Traslacional e INMUNOTERAPIA DEL CÁNCER 17.30-17.55 Poster display and coffee CP-01 UTILITY OF 18F-FDG PET/CT IN DETECTING IMMUNE-RELATED ADVERSE EVENTS INDUCED BY IMMUNOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS Patty Flores, HD1; Choque Plata, MV2 1Centro de Medicina Nuclear y Radioterapia El Alto – ABEN. La Paz, Bolivia. 2Consultorio Médico Victoria. La Paz, Bolivia CP-02 ELEVATED LEPTIN LEVELS ARE LINKED TO INFLAMMATION AND POORER TREATMENT RESPONSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA REGARDLESS OF BODY MASS INDEX Lourdes Hontecillas-Prieto1,2,3†; Daniel J. García-Domínguez2,4†; Carlos Jiménez-Cortegana2; Esteban Nogales-Fernández3,5, Natalia Palazón-Carrión3,5 Alejandro Martín García-Sancho6, Eduardo Ríos-Herranz7, Josep Gumà-Padrò8, Mariano ProvencioPulla9, Antonio Rueda-Domínguez10, Luis de la Cruz-Merino3,4,5, Víctor Sánchez-Margalet1,2,4; 1Clinical Biochemistry Service, Virgen Macarena University Hospital, University of Seville, Seville, Spain. 2Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain. 3Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain. 4Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain. 5Department of Medicine, University of Seville, Seville, Spain. 6Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain. 7Department of Hematology, Hospital Universitario de Valme, Seville, Spain. 8Department of Clinical Oncology, Hospital Universitari Sant Joan de Reus URV, IISPV, Reus, Spain. 9Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, Madrid, Spain. 10Department of Hematology/Clinical Oncology, Hospital Costa del Sol, Marbella, Spain. †These authors contributed equally to this work as first authors. CP-03 ENHANCING IMMUNE RESPONSES IN CANCER VIROTHERAPY: ONCOLYTIC ADENOVIRUSES ARMED WITH A BISPECIFIC T CELL ENGAGER TARGETING FOLATE RECEPTOR ALPHA FOR THE TREATMENT OF OVARIAN CANCER Fiol, P 1; Alemany, R2; Moreno, R2 1IDIBELL Instituto de Investigación Biomédica de Bellvitge. L´Hospitalet de Llobregat, Barcelona. 2Institut Català d´Oncologia (ICO) - IDIBELL Instituto de Investigación Biomédica de Bellvitge. L´Hospitalet de Llobregat, Barcelona CP-04 EFFICIENT IN VIVO ACTIVITY OF GRANULYSIN-BASED NANOIMMUNOLIPOSOMES DIRECTED AGAINST THE MUC-1/TN ANTIGEN IN A PANCREATIC TUMOR MODEL Anel Bernal, LA1; Tobajas de la Fuente, AP1; de la Torre Cabezón, M1; Ibáñez Pérez, R1; Hurtado Guerrero, R2; Martínez Lostao, L3 1Grupo de Apoptosis, Inmunidad y Cáncer, Universidad de Zaragoza. Zaragoza. 2Instituto de Investigación Biocomputación y Física de Sistemas Complejos. Zaragoza. 3Departmento de Microbiología, Pediatría, Radiología y Salud Pública, Universidad de Zaragoza – BIFI. Zaragoza
RkJQdWJsaXNoZXIy MTQzMjMwMg==